- Home
- DNLI vs ARCB Comparison
DNLI vs ARCB Comparison
Compare DNLI & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- ARCB
- Stock Information
- Founded
- DNLI 2013
- ARCB 1923
- Country
- DNLI United States
- ARCB United States
- Employees
- DNLI N/A
- ARCB N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- ARCB Trucking Freight/Courier Services
- Sector
- DNLI Health Care
- ARCB Industrials
- Exchange
- DNLI Nasdaq
- ARCB Nasdaq
- Market Cap
- DNLI 2.1B
- ARCB 1.9B
- IPO Year
- DNLI 2017
- ARCB N/A
- Fundamental
- Price
- DNLI $13.60
- ARCB $70.58
- Analyst Decision
- DNLI Strong Buy
- ARCB Buy
- Analyst Count
- DNLI 16
- ARCB 13
- Target Price
- DNLI $37.57
- ARCB $107.00
- AVG Volume (30 Days)
- DNLI 1.3M
- ARCB 303.8K
- Earning Date
- DNLI 05-06-2025
- ARCB 04-29-2025
- Dividend Yield
- DNLI N/A
- ARCB 0.69%
- EPS Growth
- DNLI N/A
- ARCB N/A
- EPS
- DNLI N/A
- ARCB 7.31
- Revenue
- DNLI N/A
- ARCB $4,179,019,000.00
- Revenue This Year
- DNLI N/A
- ARCB $4.67
- Revenue Next Year
- DNLI $497.02
- ARCB $7.02
- P/E Ratio
- DNLI N/A
- ARCB $9.53
- Revenue Growth
- DNLI N/A
- ARCB N/A
- 52 Week Low
- DNLI $13.30
- ARCB $68.83
- 52 Week High
- DNLI $33.33
- ARCB $153.60
- Technical
- Relative Strength Index (RSI)
- DNLI 34.19
- ARCB 31.65
- Support Level
- DNLI $13.67
- ARCB $72.77
- Resistance Level
- DNLI $14.84
- ARCB $75.08
- Average True Range (ATR)
- DNLI 0.77
- ARCB 2.61
- MACD
- DNLI 0.12
- ARCB 0.54
- Stochastic Oscillator
- DNLI 9.90
- ARCB 23.09
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About ARCB ArcBest Corporation
ArcBest Corp is engaged in logistics operations. The company operates in two operating segments, The Asset-Based segment includes the results of operations of ABF Freight System, Inc. and certain other subsidiaries. The segment operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed LTL services. The services including freight transportation related to managed transportation solutions and other services. The Asset-Light segment includes the results of operations of the Company's service offerings in truckload, ground expedite, dedicated, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.